Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewDermatologyMetabolism Open Access | 10.1172/jci.insight.189177

Epidermal NAD+ deficiency induces IL-36-mediated skin inflammation and acanthosis

Taiki Seki,1 Jun-Dal Kim,2 Yasuhito Yahara,1 Hitoshi Uchida,1 Keisuke Yaku,1 Mariam Karim,1 Teruhiko Makino,2 Tadamichi Shimizu,2 and Takashi Nakagawa1

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Seki, T. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Kim, J. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Yahara, Y. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Uchida, H. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Yaku, K. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Karim, M. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Makino, T. in: PubMed | Google Scholar

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Shimizu, T. in: PubMed | Google Scholar |

1Department of Molecular and Medical Pharmacology, University of Toyama, Toyama, Japan

2Division of Complex Biosystem Research, University of Toyama, Toyama, Japan

Find articles by Nakagawa, T. in: PubMed | Google Scholar |

Published February 10, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.189177.
Copyright © 2026, Seki et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published February 10, 2026 - Version history
View PDF
Abstract

Nicotinamide adenine dinucleotide (NAD⁺) is essential for cellular metabolism, DNA repair, and stress responses. NAD+ is synthesized from nicotinamide, nicotinic acid (collectively termed niacin), and tryptophan. In humans, deficiencies in these nutrients result in pellagra, marked by dermatitis, diarrhea, and dementia. The dermatitis associated with pellagra typically manifests as photodermatosis in sun-exposed areas. This study examined the effects of NAD+ deficiency on skin homeostasis using epidermis-specific Nampt conditional knockout (cKO) mice. These mice displayed substantial NAD⁺ depletion, reduced poly(ADP-ribose) polymerase (PARP) activity, and increased DNA damage. Consequently, Nampt cKO mice developed spontaneous skin inflammation and epidermal hyperplasia. RNA sequencing and immunohistochemical analyses demonstrated increased interleukin-36 (IL-36) cytokine expression, suggesting that DNA repair-related genomic stress triggers keratinocyte-driven IL-36 production, which promotes inflammation. Furthermore, reduced collagen17A1 expression and elevated thymic stromal lymphopoietin (TSLP) levels were observed. NAD+ repletion by transdermal supplementation of nicotinamide mononucleotide (NMN) suppressed the rise of IL-36 levels and skin inflammation. These findings underscore the importance of Nampt-mediated NAD⁺ metabolism for epidermal stability and indicate that NAD⁺ depletion may contribute to IL-36-mediated skin inflammation, offering insights for therapeutic strategies in inflammatory skin disorders.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View Supplemental Table 1

View Supplemental Table 2

View Supplemental Table 3

Version history
  • Version 1 (February 10, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts